Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells
Name
nihms834771.pdf
Size
876.48 KB
Format
Adobe PDF
Checksum (MD5)
4c52c4f7e1b24c7cccf2a811cf23c580
Author(s)
Mueller, Stephanie
Vrbanac, Vlad
Genel, Shy
Tager, Andrew M.
Allen, Todd M.
Jones, Richard Bradley
Kumari, Sudha
Walker, Bruce
Irvine, Darrell J
Date Issued
February 2017
Journal
Biomaterials
Publisher
Elsevier BV
Citation
Jones, R. Brad, Stephanie Mueller, Sudha Kumari, Vlad Vrbanac, Shy Genel, Andrew M. Tager, Todd M. Allen, Bruce D. Walker, and Darrell J. Irvine. “Antigen Recognition-Triggered Drug Delivery Mediated by Nanocapsule-Functionalized Cytotoxic T-Cells.” Biomaterials 117 (February 2017): 44–53.
Version
Author's final manuscript
Abstract
Cytotoxic T-Lymphocytes (CTLs) kill pathogen-infected or transformed cells following interaction of their T-cell receptors (TCRs) with foreign (e.g. virus-derived) peptides bound to MHC-I molecules on the target cell. TCR binding triggers CTLs to secrete perforin, which forms pores in the target cell membrane, promoting target death. Here, we show that by conjugating drug-loaded lipid nanoparticles to the surface of CTLs, their lytic machinery can be co-opted to lyse the cell-bound drug carrier, providing triggered release of drug cargo upon target cell recognition. Protein encapsulated in T-cell-bound nanoparticles was released following culture of CTLs with target cells in an antigen dose- and perforin-dependent manner and coincided with target cell lysis. Using this approach, we demonstrate the capacity of HIV-specific CTLs to deliver an immunotherapeutic agent to an anatomical site of viral replication. This strategy provides a novel means to couple drug delivery to the action of therapeutic cells in vivo.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/J.BIOMATERIALS.2016.11.048
